BM
BOBBY MCMILLIN
ARNOLD & PORTER KAYE SCHOLER LLP · Washington, DC · registered since 2024
Registered · LDAActive
At a glance
Registered since
2024
Senate LDA system
Clients
11
last 3 years
Filings
32
7 agencies contacted
Activity
filings by quarter
Works on
Background
Government experience
General Counsel
Senate Committee on Health, Education, Labor, & Pensions
HELP) (2015-2019); Counsel, Senate HELP Committee (2015); Counsel, Sen. Chambliss (2013-2015); Regional Rep., Sen. Chambliss (2012-2013); Press Intern, Sen. Chambliss (2007
Disclosed on LD-2 filings
Career
AP
Specific issues
Issues related to implementation of the Inflation Reduction Act (IRA, P.L. 117-169).
Issues related to R&D tax credits, including the Tax Relief for American Families and Workers Act of 2024 (H.R. 7024).
Issues related to access, coverage, and payment for cancer drugs. Issues regarding the 340B program, including the Bipartisan 340B Senate Working Group's discussion draft of the Supporting Underserved and Strengthening Transparency, Accountability, and Integrity Now and for the Future of 340B Act (SUSTAIN 340B Act). Issues related to biopharmaceutical intellectual property and patent matters.
Issues related to access, coverage, and payment for cancer drugs. Issues regarding the Inflation Reduction Act (Pub. L. No. 117-169), including implementation. Issues related to the Small Biotech Innovation Act (S. 5029).
Issues related to biopharmaceutical intellectual property and patent matters.
Issues and legislation related to access to gene therapies and treatment of rare diseases; the Medicaid VBPs for Patients (MVP) Act (H.R. 2666); Creating Hope Reauthorization Act (H.R. 7384 / S. 4583); Patient Access Act (H.R. 9184)
Clients
Filing history
PHARMAESSENTIA USA CORPORATION
EXELIXIS, INC.
FRATERNAL GOVERNMENT RELATIONS COALITION
GENETIX BIOTHERAPEUTICS, INC.
NOVO NORDISK, INC.
GRIFOLS SHARED SERVICES NORTH AMERICA, INC.
NOVO NORDISK A/S
WILLIAM & MARY FOUNDATION
CALBRIGHT COLLEGE
PHARMAESSENTIA USA CORPORATION
PHARMAESSENTIA USA CORPORATION
NOVO NORDISK A/S